 |
|
|
|
|
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
 |
|
|
|
|
|
 |
|
|
|
|
Masliah E. on NEWS: Toxic Synuclein Corrupts Native in Wild-Type Mice, This is a very important paper that further supports the role of a prion-like propagation of... 20 Nov 2012.
|
|
|
 |
|
|
Masliah E. on PAPER: Bartels T. et al., 2011, The study of Bartels et al. on α-synuclein is very interesting and provocative, and has the... 19 Aug 2011.
|
|
|
|
|
|
Masliah E. on PAPER: Lee JH. et al., 2010, The recent report from Randy Nixon and colleagues is an interesting development in the story of... 16 Jun 2010.
|
|
|
|
|
|
Lee S, Masliah E. on NEWS: Traveling Tau—A New Paradigm for Tau- and Other Proteinopathies?, Propagation and Prion-like Spreading of Proteins in Common Neurodegenerative Disorders; New... 18 Jun 2009.
|
|
|
|
|
|
Masliah E. on NEWS: Dopamine Renders α-Synuclein Toxic to Neurons, We need to remember that many studies, such as this one by Yankner, involve in vitro systems... 31 May 2002.
|
|
|
|
|
|
Masliah E. on NEWS: Viral Transgenic Techniques Pay Off In Parkinson's Models, Use of viral vector for targeting transgene expression in a region- and time-specific manner was... 3 Apr 2002.
|
|
|
|
|
|
|
1 to 6 of 6 results |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
The ALS Forum is a web-based collaborative effort to bring together valuable ALS-related resources for use by researchers worldwide in both academia and industry-based settings.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Should the FDA be allowed to use data from overseas clinical trials? |
|
|
|
|
|
|
|
|
|
|
|
Absolutely, we are running out of viable subjects in the U.S. |
|
|
|
|
|
|
 9 |
|
|
|
|
|
|
|
|
|
|
|
Yes, so long as the data is reliable |
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
No, the trials are not as rigorous |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
No, the data should be repeated in the U.S. |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
No, the drug sponsors are just trying to cut corners |
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Responses: 51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
Archived Polls |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
 Antibodies
Cell Lines
Collaborators
Papers
Research Participants
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Home
Check out our upcoming Webinar: 
